Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (15255)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 7, 2018 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mumolo MG, Bertani L, Ceccarelli L, Laino G, Di Fluri G, Albano E, Tapete G, Costa F. From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting. World J Gastroenterol 2018; 24(33): 3681-3694 [PMID: 30197475 DOI: 10.3748/wjg.v24.i33.3681] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3214/full/v24/i33/3681.htm |
| Number | Citing Articles |
| 1 |
James P. Campbell, Claudia Zierold, Ashli M. Rode, Frank A. Blocki, Byron P. Vaughn. Clinical Performance of a Novel LIAISON Fecal Calprotectin Assay for Differentiation of Inflammatory Bowel Disease From Irritable Bowel Syndrome. Journal of Clinical Gastroenterology 2021; 55(3): 239 doi: 10.1097/MCG.0000000000001359
|
| 2 |
Shin Young Park, Sang Pyung Lee, Woo Jin Kim. Fecal Calprotectin Is Increased in Stroke. Journal of Clinical Medicine 2021; 11(1): 159 doi: 10.3390/jcm11010159
|
| 3 |
Fernando Magro, Samuel Fernandes, Marta Patita, Bruno Arroja, Paula Lago, Isadora Rosa, Helena Tavares de Sousa, Paula Ministro, Irina Mocanu, Ana Vieira, Joana Castela, Joana Moleiro, Joana Roseira, Eugénia Cancela, Paula Sousa, Francisco Portela, Luís Correia, Paula Moreira, Sandra Dias, Joana Afonso, Silvio Danese, Laurent Peyrin-Biroulet, Katarina M Vucicevic, Mafalda Santiago. The Influence of Subclinical Active Inflammation on IFX Pharmacokinetic Modeling and Disease Progression Assessment: Findings from a Prospective Real-World Study in Inflammatory Bowel Disease Patients. Journal of Crohn's and Colitis 2024; doi: 10.1093/ecco-jcc/jjae014
|
| 4 |
Inês Silva, João Estarreja, Rui Pinto, Vanessa Mateus. Efficacy and safety of erythropoietin in a chronic model of Inflammatory Bowel Disease. Biomedicine & Pharmacotherapy 2022; 156: 113944 doi: 10.1016/j.biopha.2022.113944
|
| 5 |
Mihaela Dranga, Cătălina Mihai, Otilia Gavrilescu, Cristina Cijevschi Prelipcean, Iolanda Valentina Popa. Enhancing Calprotectin’s Predictive Power as a Biomarker of Endoscopic Activity in Ulcerative Colitis: A Machine Learning Use Case. Biomedicines 2024; 12(3): 475 doi: 10.3390/biomedicines12030475
|
| 6 |
Guanglin Cui, Qingbo Fan, Zhenfeng Li, Rasmus Goll, Jon Florholmen. Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers. eBioMedicine 2021; 66: 103329 doi: 10.1016/j.ebiom.2021.103329
|
| 7 |
Sabrina Just Kousgaard, Thomas Yssing Michaelsen, Hans Linde Nielsen, Karina Frahm Kirk, Mads Albertsen, Ole Thorlacius-Ussing. The Microbiota Profile in Inflamed and Non-Inflamed Ileal Pouch–Anal Anastomosis. Microorganisms 2020; 8(10): 1611 doi: 10.3390/microorganisms8101611
|
| 8 |
Júlia Faria Campos, Gustavo Gomes Resende, Alfredo José Afonso Barbosa, Silas Castro de Carvalho, Junia Aguiar Lage, Pedro Ferrari Sales Cunha, Stela Cristina Silva de Souza, Maria de Lourdes Abreu Ferrari. Fecal calprotectin as a biomarker of microscopic bowel inflammation in patients with spondyloarthritis. International Journal of Rheumatic Diseases 2022; 25(9): 1078 doi: 10.1111/1756-185X.14388
|
| 9 |
M. Pehrsson, M. S. Alexdóttir, M. A. Karsdal, P. Thakker, J.H. Mortensen. Novel fibro-inflammatory biomarkers associated with disease activity in patients with Crohn’s disease. Expert Review of Gastroenterology & Hepatology 2023; 17(6): 575 doi: 10.1080/17474124.2023.2212158
|
| 10 |
Pawel Petryszyn, Aleksandra Staniak, Agnieszka Wolosianska, Pawel Ekk-Cierniakowski. Faecal calprotectin as a diagnostic marker of inflammatory bowel disease in patients with gastrointestinal symptoms: meta-analysis. European Journal of Gastroenterology & Hepatology 2019; 31(11): 1306 doi: 10.1097/MEG.0000000000001509
|
| 11 |
Cristina Carretero, Alejandro Bojorquez, Rami Eliakim, Nikolaos Lazaridis. Updates in the diagnosis and management of small-bowel Crohn's disease. Best Practice & Research Clinical Gastroenterology 2023; : 101855 doi: 10.1016/j.bpg.2023.101855
|
| 12 |
Anna Luisa Bathe, Eirini Mavropoulou, Nicolae-Catalin Mechie, Golo Petzold, Volker Ellenrieder, Steffen Kunsch, Ahmad Amanzada, Bruno Bonaz. Impact of faecal calprotectin measurement on clinical decision-making in patients with Crohn’s disease and ulcerative colitis. PLOS ONE 2019; 14(10): e0223893 doi: 10.1371/journal.pone.0223893
|
| 13 |
Zehra Betul Pakoz, Muge Ustaoglu, Sezgin Vatansever, Elif Saritas Yuksel, Firdevs Topal, Gian Luigi Adani. Serum Immune-Inflammation Index Assessment in the Patients with Ulcerative Colitis. Gastroenterology Research and Practice 2022; 2022: 1 doi: 10.1155/2022/9987214
|
| 14 |
Cecilia Suarez-Carantoña, Argeme Rodriguez-Torres, Adrian Viteri-Noel, Vicente Pintado, Sergio Garcia-Fernandez, Daniel Mora-Pimentel, Rosa Escudero-Sanchez, Fuencisla Martin-Jusdado, Santiago Moreno, Javier Cobo. Usefulness of Fecal Calprotectin in the Management of Patients with Toxigenic Clostridioides difficile. Journal of Clinical Medicine 2021; 10(8): 1627 doi: 10.3390/jcm10081627
|
| 15 |
Daniela Fluxa, Maria T. Abreu. Therapeutic targets in inflammatory bowel disease. Revista Médica Clínica Las Condes 2019; 30(4): 315 doi: 10.1016/j.rmclc.2019.06.008
|
| 16 |
Riccardo Capecchi, Paola Migliorini, Federico Zanzi, Simona Maltinti, Ilaria Puxeddu, Nicola de Bortoli, Massimo Bellini, Francesco Costa, Santino Marchi, Lorenzo Bertani. Ig Glycosylation in Ulcerative Colitis: It’s Time for New Biomarkers. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.654319
|
| 17 |
Amr Shaaban Hanafy, Mohamed Sorour Mohamed, Ahmed A. Alnagar. Ascitic Calprotectin as an early predictor of hepatocellular carcinoma in patients with cirrhotic ascites. Journal of Cancer Research and Clinical Oncology 2020; 146(12): 3207 doi: 10.1007/s00432-020-03363-y
|
| 18 |
Macarena Gompertz, Rocío Sedano. Manifestaciones clínicas y endoscópicas en enfermedad inflamatoria intestinal. Revista Médica Clínica Las Condes 2019; 30(4): 273 doi: 10.1016/j.rmclc.2019.06.002
|
| 19 |
Rocío Sedano Muñoz, Rodrigo Quera Pino, Patricio Ibáñez Lazo, Carolina Figueroa Corona, Lilian Flores Pérez. Aminosalicylates, thiopurines and methotrexate in inflammatory bowel disease: Is it possible to discontinue the treatment?. Gastroenterología y Hepatología (English Edition) 2019; 42(5): 339 doi: 10.1016/j.gastre.2019.01.016
|
| 20 |
Inês Silva, Rita Correia, Rui Pinto, Vanessa Mateus. Hemin Ameliorates the Inflammatory Activity in the Inflammatory Bowel Disease: A Non-Clinical Study in Rodents. Biomedicines 2022; 10(8): 2025 doi: 10.3390/biomedicines10082025
|
| 21 |
Eslam Safwat, Manar Salah, Hany Hussein. Faecal calprotectin levels after rifaximin treatment in patients with irritable bowel syndrome with diarrhoea: A single-center prospective study. Arab Journal of Gastroenterology 2020; 21(4): 273 doi: 10.1016/j.ajg.2020.08.003
|
| 22 |
Lorenzo Bertani, Maria Gloria Mumolo, Gherardo Tapete, Eleonora Albano, Giovanni Baiano Svizzero, Federico Zanzi, Linda Ceccarelli, Massimo Bellini, Santino Marchi, Francesco Costa. Fecal calprotectin: current and future perspectives for inflammatory bowel disease treatment. European Journal of Gastroenterology & Hepatology 2020; 32(9): 1091 doi: 10.1097/MEG.0000000000001731
|
| 23 |
Jonas Varkey. Graft assessment for acute rejection after intestinal transplantation: current status and future perspective. Scandinavian Journal of Gastroenterology 2021; 56(1): 13 doi: 10.1080/00365521.2020.1847318
|
| 24 |
Fang Chen, Yue Hu, Yi-Hong Fan, Bin Lv. Clinical Value of Fecal Calprotectin in Predicting Mucosal Healing in Patients With Ulcerative Colitis. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.679264
|
| 25 |
Joseph Amara, Youakim Saliba, Joelle Hajal, Viviane Smayra, Jules-Joel Bakhos, Raymond Sayegh, Nassim Fares. Circadian Rhythm Disruption Aggravates DSS-Induced Colitis in Mice with Fecal Calprotectin as a Marker of Colitis Severity. Digestive Diseases and Sciences 2019; 64(11): 3122 doi: 10.1007/s10620-019-05675-7
|
| 26 |
John Clore, Shelly Dean, Abigail V.W. Kumral, Eva Manthe, Serwa Ertl. Teenager With Abdominal Pain and Decreased Appetite. Pediatrics 2020; 145(5) doi: 10.1542/peds.2019-2233
|
| 27 |
Xijing Huang, Ya Liu, Zhou Zhou, Yan Pan, Yinghui Zhang, Caiping Gao, Chong He. Clinical significance of the C-reactive protein-to-bilirubin ratio in patients with ulcerative colitis. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1227998
|
| 28 |
Catherine R. Rowan, Richard J.M. Ingram. Today and tomorrow: the use of biomarkers in inflammatory bowel disease. Canadian IBD Today 2023; doi: 10.58931/cibdt.2023.1320
|
| 29 |
Emiko Mizoguchi, Renuka Subramaniam, Toshiyuki Okada, Atsushi Mizoguchi. A Review of Selected IBD Biomarkers: From Animal Models to Bedside. Diagnostics 2021; 11(2): 207 doi: 10.3390/diagnostics11020207
|
| 30 |
Alain Schoepfer, Stephan R. Vavricka, Beat Brüngger, Eva Blozik, Caroline Bähler. Systematic analysis of therapeutic patterns and healthcare use during 12 months before inflammatory bowel disease-related hospitalization in Switzerland. European Journal of Gastroenterology & Hepatology 2020; 32(3): 350 doi: 10.1097/MEG.0000000000001616
|
| 31 |
Arta Aliu, Daan H. C. A. Bosch, Daniel Keszthelyi, Ashkan Rezazadeh Ardabili, Jean‐Frederic Colombel, Rachel Sawyer, Hans Törnblom, Ailsa Hart, Daisy M. A. E. Jonkers, Marieke J. Pierik, Zlatan Mujagic. Review article: A practical approach to persistent gastrointestinal symptoms in inflammatory bowel disease in remission. Alimentary Pharmacology & Therapeutics 2024; doi: 10.1111/apt.17988
|
| 32 |
Lorenzo Bertani, Federico Rossari, Brigida Barberio, Maria Giulia Demarzo, Gherardo Tapete, Eleonora Albano, Giovanni Baiano Svizzero, Linda Ceccarelli, Maria Gloria Mumolo, Chiara Brombin, Nicola de Bortoli, Massimo Bellini, Santino Marchi, Giorgia Bodini, Edoardo Savarino, Francesco Costa. Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated With Anti-TNF: Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio. Inflammatory Bowel Diseases 2020; 26(10): 1579 doi: 10.1093/ibd/izaa062
|
| 33 |
Marko Kumric, Piero Marin Zivkovic, Tina Ticinovic Kurir, Josip Vrdoljak, Marino Vilovic, Dinko Martinovic, Andre Bratanic, Ivan Kresimir Lizatovic, Josko Bozic. Role of B-Cell Activating Factor (BAFF) in Inflammatory Bowel Disease. Diagnostics 2021; 12(1): 45 doi: 10.3390/diagnostics12010045
|
| 34 |
Sara Ramió‐Pujol, Joan Amoedo, Mariona Serra‐Pagès, Leyanira Torrealba, Anna Bahí, Marta Serrano, Marta Malagón, Gemma Ibáñez‐Sanz, Pau Gilabert, Ingrid Marin, Paola Torres, Fiorella Cañete, Miriam Mañosa, Ariadna Clos, Josep Oriol Miquel‐Cusachs, David Busquets, Míriam Sàbat, Jordi Serra, Alan C. Moss, Eugeni Domènech, Jordi Guardiola, Fermín Mearín, Javier Santos, Librado Jesús Garcia‐Gil, Xavier Aldeguer. A novel distinctive form of identification for differential diagnosis of irritable bowel syndrome, inflammatory bowel disease, and healthy controls. GastroHep 2020; 2(5): 193 doi: 10.1002/ygh2.417
|
| 35 |
Qing Xiao, Fengting Yu, Liting Yan, Hongxin Zhao, Fujie Zhang. Alterations in circulating markers in HIV/AIDS patients with poor immune reconstitution: Novel insights from microbial translocation and innate immunity. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1026070
|
| 36 |
Ho Min Yong, Sung-Jo Park, Seong Ran Jeon, Heesu Park, Hyun Gun Kim, Tae Hee Lee, Junseok Park, Jin-Oh Kim, Joon Seong Lee, Bong Min Ko, Hyeon Jeong Goong, Suyeon Park. Endoscopy within 7 days after detecting high calprotectin levels can be useful for therapeutic decision-making in ulcerative colitis. Medicine 2021; 100(34): e27065 doi: 10.1097/MD.0000000000027065
|
| 37 |
Hiroshi Nakase, Motohiro Esaki, Fumihito Hirai, Taku Kobayashi, Katsuyoshi Matsuoka, Minoru Matsuura, Makoto Naganuma, Masayuki Saruta, Kiichiro Tsuchiya, Motoi Uchino, Kenji Watanabe, Tadakazu Hisamatsu, Akira Andoh, Shigeki Bamba, Motohiro Esaki, Mikihiro Fujiya, Kitaro Futami, Keisuke Hata, Fumihito Hirai, Sakiko Hiraoka, Tadakazu Hisamatsu, Ryota Hokari, Shunji Ishihara, Soichiro Ishihara, Michio Itabashi, Yoichi Kakuta, Jun Kato, Shingo Kato, Takehiko Katsurada, Kazuya Kitamura, Kiyonori Kobayashi, Taku Kobayashi, Kazutaka Koganei, Atsuo Maemoto, Toshiyuki Matsui, Takayuki Matsumoto, Katsuyoshi Matsuoka, Minoru Matsuura, Satoshi Motoya, Masakazu Nagahori, Makoto Naganuma, Yuji Naito, Shiro Nakamura, Hiroshi Nakase, Haruhiko Ogata, Kazuichi Okazaki, Hirotake Sakuraba, Masayuki Saruta, Shinichiro Shinzaki, Ken Sugimoto, Akira Sugita, Yasuo Suzuki, Kenichi Takahashi, Tomohisa Takagi, Kento Takenaka, Ken Takeuchi, Kiichiro Tsuchiya, Tomoyuki Tsujikawa, Motoi Uchino, Fumiaki Ueno, Kenji Watanabe, Mamoru Watanabe, Takayuki Yamamoto, Kaoru Yokoyama, Atsushi Yoshida, Naoki Yoshimura. Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 2021. Journal of Gastroenterology 2023; 58(4): 313 doi: 10.1007/s00535-023-01958-z
|
| 38 |
Lorenzo Bertani, Matteo Fornai, Marco Fornili, Luca Antonioli, Laura Benvenuti, Gherardo Tapete, Giovanni Baiano Svizzero, Linda Ceccarelli, Maria Gloria Mumolo, Laura Baglietto, Nicola de Bortoli, Massimo Bellini, Santino Marchi, Francesco Costa, Corrado Blandizzi. Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab. Alimentary Pharmacology & Therapeutics 2020; 52(2): 284 doi: 10.1111/apt.15870
|
| 39 |
David Atuahene, Annalisa Costale, Elisa Martello, Alessandro Mannelli, Elisabetta Radice, Davide Giuseppe Ribaldone, Biagina Chiofalo, Bruno Stefanon, Giorgia Meineri. A Supplement with Bromelain, Lentinula edodes, and Quercetin: Antioxidant Capacity and Effects on Morphofunctional and Fecal Parameters (Calprotectin, Cortisol, and Intestinal Fermentation Products) in Kennel Dogs. Veterinary Sciences 2023; 10(8): 486 doi: 10.3390/vetsci10080486
|
| 40 |
Elena Carmona-Rocha, Lluís Puig. Ixekizumab for the treatment of moderate-to-severe plaque psoriasis: the first septennium. Immunotherapy 2023; 15(15): 1209 doi: 10.2217/imt-2023-0013
|
| 41 |
Monica State, Lucian Negreanu, Theodor Voiosu, Andrei Voiosu, Paul Balanescu, Radu Bogdan Mateescu. Surrogate markers of mucosal healing in inflammatory bowel disease: A systematic review. World Journal of Gastroenterology 2021; 27(16): 1828-1840 doi: 10.3748/wjg.v27.i16.1828
|
| 42 |
Bitte Sjöström, Anders Bredberg, Thomas Mandl, Lucía Alonso-Magdalena, Bodil Ohlsson, Shahram Lavasani, Mehrnaz Nouri, Gunnel Henriksson. Increased intestinal permeability in primary Sjögren’s syndrome and multiple sclerosis. Journal of Translational Autoimmunity 2021; 4: 100082 doi: 10.1016/j.jtauto.2021.100082
|
| 43 |
Jared Matson, Sonia Ramamoorthy, Nicole E. Lopez. The Role of Biomarkers in Surgery for Ulcerative Colitis: A Review. Journal of Clinical Medicine 2021; 10(15): 3362 doi: 10.3390/jcm10153362
|
| 44 |
Shin Young Park. Age-Related Fecal Calprotectin Concentrations in Healthy Adults. The Korean Journal of Clinical Laboratory Science 2020; 52(3): 181 doi: 10.15324/kjcls.2020.52.3.181
|
| 45 |
Norhamizah Roshidi, Norsyahida Arifin, Francisco Gonzalez Salazar. Disease Biomarkers of Giardiasis. Journal of Parasitology Research 2022; 2022: 1 doi: 10.1155/2022/1932518
|
| 46 |
Lucia Fontanelli Sulekova, Simona Gabrielli, Federica Furzi, Giovanni Luigi Milardi, Elisa Biliotti, Maurizio De Angelis, Giancarlo Iaiani, Caterina Fimiani, Myriam Maiorano, Simonetta Mattiucci, Gloria Taliani. Molecular characterization of Blastocystis subtypes in HIV-positive patients and evaluation of risk factors for colonization. BMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-4537-7
|
| 47 |
Matthew K. Smith, Jay Pai, Remo Panaccione, Paul Beck, Jose G. Ferraz, Humberto Jijon. Crohn’s-like disease in a patient exposed to anti-Interleukin-17 blockade (Ixekizumab) for the treatment of chronic plaque psoriasis: a case report. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1067-0
|
| 48 |
Jesús K. Yamamoto-Furusho, Erick A. Mendieta-Escalante, Emiko Mizoguchi. Diagnostic utility of the neutrophil-platelet ratio as a novel marker of activity in patients with Ulcerative Colitis. PLOS ONE 2020; 15(4): e0231988 doi: 10.1371/journal.pone.0231988
|
| 49 |
Karma Yeshi, Roland Ruscher, Luke Hunter, Norelle L. Daly, Alex Loukas, Phurpa Wangchuk. Revisiting Inflammatory Bowel Disease: Pathology, Treatments, Challenges and Emerging Therapeutics Including Drug Leads from Natural Products. Journal of Clinical Medicine 2020; 9(5): 1273 doi: 10.3390/jcm9051273
|
| 50 |
Salih TOKMAK, Ayşegül HARMANCI ÖZAKYOL. Elevated Levels of Fecal Calprotectin in Cirrhotic Patients and Spontaneous Bacterial Peritonitis. Düzce Tıp Fakültesi Dergisi 2019; 21(3): 214 doi: 10.18678/dtfd.653549
|
| 51 |
Katrine Risager Christensen, Casper Steenholdt, Sine Buhl, Jørn Brynskov, Mark Andrew Ainsworth. A systematic monitoring approach to biologic therapies in inflammatory bowel disease: patients’ and physicians’ preferences and adherence. Scandinavian Journal of Gastroenterology 2022; 57(3): 274 doi: 10.1080/00365521.2021.2002397
|
| 52 |
Roberto Trasolini, Kai Zhu, Natasha Klemm, Sophia Park, Baljinder Salh. Fecal Leukocyte Esterase, an Alternative Biomarker to Fecal Calprotectin in Inflammatory Bowel Disease: A Pilot Series. Gastro Hep Advances 2022; 1(1): 45 doi: 10.1016/j.gastha.2021.10.006
|
| 53 |
Elodie Picard, Frederic Antonio Carvalho, Francina Agosti, Emmanuel Bourinet, Denis Ardid, Alain Eschalier, Laurence Daulhac, Christophe Mallet. Inhibition of Cav3.2 calcium channels: A new target for colonic hypersensitivity associated with low‐grade inflammation. British Journal of Pharmacology 2019; 176(7): 950 doi: 10.1111/bph.14608
|
| 54 |
Silvia Marquez-Megias, Ricardo Nalda-Molina, Patricio Más-Serrano, Amelia Ramon-Lopez. Population Pharmacokinetic Model of Adalimumab Based on Prior Information Using Real World Data. Biomedicines 2023; 11(10): 2822 doi: 10.3390/biomedicines11102822
|
| 55 |
Ronald Neil Kostoff, Michael Brandon Briggs, Darja Kanduc, Darla Roye Shores, Leda Kovatsi, Alexander I. Vardavas, Alan L. Porter. Common contributing factors to COVID-19 and inflammatory bowel disease. Toxicology Reports 2021; 8: 1616 doi: 10.1016/j.toxrep.2021.08.007
|
| 56 |
Ferdinando D'Amico, David T. Rubin, Paulo Gustavo Kotze, Fernando Magro, Britta Siegmund, Taku Kobayashi, Pablo A. Olivera, Peter Bossuyt, Lieven Pouillon, Edouard Louis, Eugeni Domènech, Subrata Ghosh, Silvio Danese, Laurent Peyrin‐Biroulet. International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases. United European Gastroenterology Journal 2021; 9(4): 451 doi: 10.1002/ueg2.12069
|
| 57 |
Antonio Tursi, Walter Elisei. Role of Inflammation in the Pathogenesis of Diverticular Disease. Mediators of Inflammation 2019; 2019: 1 doi: 10.1155/2019/8328490
|
| 58 |
Fabio Corsi, Luca Sorrentino, Sara Albasini, Francesco Colombo, Maria Cigognini, Alessandro Massari, Carlo Morasso, Serena Mazzucchelli, Francesca Piccotti, Sandro Ardizzone, Gianluca M. Sampietro, Marta Truffi. Circulating Fibroblast Activation Protein as Potential Biomarker in Patients With Inflammatory Bowel Disease. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.725726
|
| 59 |
Rocío Sedano Muñoz, Rodrigo Quera Pino, Patricio Ibáñez Lazo, Carolina Figueroa Corona, Lilian Flores Pérez. Aminosalicilatos, tiopurínicos y metotrexato en la enfermedad inflamatoria intestinal, ¿es posible suspender el tratamiento?. Gastroenterología y Hepatología 2019; 42(5): 339 doi: 10.1016/j.gastrohep.2019.01.013
|
| 60 |
Mia Bendix, Anders Dige, Søren Peter Jørgensen, Jens Frederik Dahlerup, Bo Martin Bibby, Bent Deleuran, Jørgen Agnholt. Seven Weeks of High-Dose Vitamin D Treatment Reduces the Need for Infliximab Dose-Escalation and Decreases Inflammatory Markers in Crohn’s Disease during One-Year Follow-Up. Nutrients 2021; 13(4): 1083 doi: 10.3390/nu13041083
|
| 61 |
V. Premjeyanth, A. R. Shipman, K. E. Shipman. Faecal calprotectin in dermatology practice. Clinical and Experimental Dermatology 2020; 45(7): 831 doi: 10.1111/ced.14307
|
| 62 |
Weifeng Wang, Lixia Wu, Xuan Wu, Ke Li, Tianming Li, Bei Xu, Weiwei Liu. Combined analysis of serum SAP and PRSS2 for the differential diagnosis of CD and UC. Clinica Chimica Acta 2021; 514: 8 doi: 10.1016/j.cca.2020.12.014
|
| 63 |
Amy Hemperly, Marla C Dubinsky, Andres Yarur, Anita Afzali, Stephen Hanauer, Subra Kugathasan, Millie D Long, Shervin Rabizadeh, Robbyn Sockolow, Lauren Okada, Anjali Jain, Maria T Abreu, Niels Vande Casteele. Noninvasive Targeted Crohn Disease Management by Combining Endoscopic Healing Index and Therapeutic Drug Monitoring. Crohn's & Colitis 360 2021; 3(3) doi: 10.1093/crocol/otab035
|
| 64 |
Dora Grgić, Karlo Golubić, Marko Brinar, Željko Krznarić. Predictive value of faecal calprotectin in ulcerative colitis – single centre experience. Annals of Medicine 2022; 54(1): 1570 doi: 10.1080/07853890.2022.2082518
|
| 65 |
Lorenzo Bertani, Laura Baglietto, Luca Antonioli, Matteo Fornai, Gherardo Tapete, Eleonora Albano, Linda Ceccarelli, Maria Gloria Mumolo, Carolina Pellegrini, Ersilia Lucenteforte, Nicola de Bortoli, Massimo Bellini, Santino Marchi, Corrado Blandizzi, Francesco Costa. Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients. British Journal of Clinical Pharmacology 2020; 86(7): 1296 doi: 10.1111/bcp.14235
|
| 66 |
Linshan Duan, Shuyu Cheng, Long Li, Yanling Liu, Dan Wang, Guoyan Liu. Natural Anti-Inflammatory Compounds as Drug Candidates for Inflammatory Bowel Disease. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.684486
|
| 67 |
Katharina Dihm, Malin Ek, Bodil Roth, Bodil Ohlsson. Plasma AXIN1 expression exhibit negative correlations with inflammatory biomarkers and is associated with gastrointestinal symptoms in endometriosis. Biomedical Reports 2020; doi: 10.3892/br.2020.1282
|
| 68 |
Luiz G.N. de Almeida, Antoine Dufour. Proteolytic Signaling in Health and Disease. 2022; : 93 doi: 10.1016/B978-0-323-85696-6.00003-2
|
| 69 |
Carlo Morasso, Marta Truffi, Renzo Vanna, Sara Albasini, Serena Mazzucchelli, Francesco Colombo, Luca Sorrentino, Gianluca Sampietro, Sandro Ardizzone, Fabio Corsi. Raman Analysis Reveals Biochemical Differences in Plasma of Crohn’s Disease Patients. Journal of Crohn's and Colitis 2020; 14(11): 1572 doi: 10.1093/ecco-jcc/jjaa080
|
| 70 |
Yasser Rashed. Fecal Calprotectin in Children Can Differentiate Between Different Gastrointestinal Diseases. Open Access Macedonian Journal of Medical Sciences 2022; 10(B): 773 doi: 10.3889/oamjms.2022.8367
|
| 71 |
José Germán Sánchez-Hernández, Jonás Samuel Pérez-Blanco, Noemí Rebollo, Fernando Muñoz, Vanessa Prieto, María Victoria Calvo. Biomarkers of disease activity and other factors as predictors of adalimumab pharmacokinetics in inflammatory bowel disease. European Journal of Pharmaceutical Sciences 2020; 150: 105369 doi: 10.1016/j.ejps.2020.105369
|
| 72 |
Brigida Barberio, Sonia Facchin, Ilaria Patuzzi, Alexander C. Ford, Davide Massimi, Giorgio Valle, Eleonora Sattin, Barbara Simionati, Elena Bertazzo, Fabiana Zingone, Edoardo Vincenzo Savarino. A specific microbiota signature is associated to various degrees of ulcerative colitis as assessed by a machine learning approach. Gut Microbes 2022; 14(1) doi: 10.1080/19490976.2022.2028366
|
| 73 |
Min Zhu, Liqiaona Fan, Muzhou Han, Siying Zhu, Shutian Zhang, Haiyun Shi. The usefulness of fecal hemoglobin and calprotectin tests in diagnosing significant bowel diseases: a prospective study. Scandinavian Journal of Gastroenterology 2023; 58(4): 368 doi: 10.1080/00365521.2022.2133551
|
| 74 |
Mariana del Rocio Ruiz-Briseño, Judith Carolina De Arcos-Jiménez, Sarah Ratkovich-González, Karina Sánchez-Reyes, Luz A. González-Hernández, Jaime F. Andrade-Villanueva, Monserrat Alvarez-Zavala. Association of intestinal and systemic inflammatory biomarkers with immune reconstitution in HIV+ patients on ART. Journal of Inflammation 2020; 17(1) doi: 10.1186/s12950-020-00262-4
|
| 75 |
Eamonn M.M. Quigley. Editorial. Current Opinion in Gastroenterology 2019; 35(1): 25 doi: 10.1097/MOG.0000000000000496
|
| 76 |
Tyler McKechnie, Yung Lee, Colin Kruse, Karim Ramji, Jeremy E. Springer, Trevor Wood, Aristithes G. Doumouras, Dennis Hong, Cagla Eskicioglu. The role of fecal calprotectin in the diagnosis of acute pouchitis following IPAA for ulcerative colitis: a systematic clinical review. International Journal of Colorectal Disease 2020; 35(9): 1619 doi: 10.1007/s00384-020-03669-w
|
| 77 |
Valeria Carnazzo, Serena Redi, Valerio Basile, Patrizia Natali, Francesca Gulli, Francesco Equitani, Mariapaola Marino, Umberto Basile. Calprotectin: two sides of the same coin. Rheumatology 2024; 63(1): 26 doi: 10.1093/rheumatology/kead405
|
| 78 |
Lorenzo Bertani, Gian Paolo Caviglia, Luca Antonioli, Rinaldo Pellicano, Sharmila Fagoonee, Marco Astegiano, Giorgio Maria Saracco, Elisabetta Bugianesi, Corrado Blandizzi, Francesco Costa, Davide Giuseppe Ribaldone. Serum Interleukin-6 and -8 as Predictors of Response to Vedolizumab in Inflammatory Bowel Diseases. Journal of Clinical Medicine 2020; 9(5): 1323 doi: 10.3390/jcm9051323
|
| 79 |
Nada Abedin, Teresa Seemann, Sandra Kleinfeld, Jessica Ruehrup, Stefani Röseler, Christian Trautwein, Konrad Streetz, Gernot Sellge. Fecal Eosinophil Cationic Protein Is a Diagnostic and Predictive Biomarker in Young Adults with Inflammatory Bowel Disease. Journal of Clinical Medicine 2019; 8(12): 2025 doi: 10.3390/jcm8122025
|
| 80 |
Ferdinando D’Amico, Stéphane Nancey, Silvio Danese, Laurent Peyrin-Biroulet. A Practical Guide for Faecal Calprotectin Measurement: Myths and Realities. Journal of Crohn's and Colitis 2021; 15(1): 152 doi: 10.1093/ecco-jcc/jjaa093
|
| 81 |
Parul Singh, Syed Azmal Ali. Multifunctional Role of S100 Protein Family in the Immune System: An Update. Cells 2022; 11(15): 2274 doi: 10.3390/cells11152274
|
| 82 |
Inês Silva, Priscila Mendes, Sofia Guerra, Rui Pinto, Vanessa Mateus. Anti-Inflammatory Effect of Topiramate in a Chronic Model of TNBS-Induced Colitis. International Journal of Molecular Sciences 2022; 23(16): 9127 doi: 10.3390/ijms23169127
|
| 83 |
Marnix Mylemans, Louis Nevejan, Stefanie Van Den Bremt, Muriel Stubbe, Bert Vander Cruyssen, Christina Moulakakis, Heike Berthold, Christian Konrad, Xavier Bossuyt, Lieve Van Hoovels. Circulating calprotectin as biomarker in neutrophil-related inflammation: Pre-analytical recommendations and reference values according to sample type. Clinica Chimica Acta 2021; 517: 149 doi: 10.1016/j.cca.2021.02.022
|
| 84 |
Erin L. Moorman, Michael Farrell, Neha Santucci, Lee Denson, Christine Le, Natoshia R. Cunningham. Elevated fecal calprotectin is linked to psychosocial complexity in pediatric functional abdominal pain disorders. BMC Research Notes 2021; 14(1) doi: 10.1186/s13104-021-05776-5
|
| 85 |
Stefan Chiriac, Catalin Victor Sfarti, Horia Minea, Carol Stanciu, Camelia Cojocariu, Ana-Maria Singeap, Irina Girleanu, Tudor Cuciureanu, Oana Petrea, Laura Huiban, Cristina Maria Muzica, Sebastian Zenovia, Robert Nastasa, Remus Stafie, Adrian Rotaru, Ermina Stratina, Anca Trifan. Impaired Intestinal Permeability Assessed by Confocal Laser Endomicroscopy—A New Potential Therapeutic Target in Inflammatory Bowel Disease. Diagnostics 2023; 13(7): 1230 doi: 10.3390/diagnostics13071230
|
| 86 |
Hyeong Ho Jo, Eun Young Kim, Jin Tae Jung, Joong Goo Kwon, Eun Soo Kim, Hyun Seok Lee, Yoo Jin Lee, Kyeong Ok Kim, Byung Ik Jang. Value of Fecal Calprotectin Measurement During the Initial Period of Therapeutic Anti-Tubercular Trial. Clinical Endoscopy 2022; 55(2): 256 doi: 10.5946/ce.2021.061
|
| 87 |
Gillian Watermeyer, Yaw Awuku, Ernst Fredericks, David Epstein, Mashiko Setshedi, Smita Devani, Wisdom Mudombi, Chris Kassianides, Leolin Katsidzira. Challenges in the management of inflammatory bowel disease in sub-Saharan Africa. The Lancet Gastroenterology & Hepatology 2022; 7(10): 962 doi: 10.1016/S2468-1253(22)00048-6
|
| 88 |
Parisa Khosravi, Saeid Abroun, Saeid Kaviani, Saman Masoudifar, Homayoun Sarough Farahani, Antonio Solimando. Calprotectin as new potential clinical marker for multiple myeloma. PLOS ONE 2023; 18(3): e0282841 doi: 10.1371/journal.pone.0282841
|
| 89 |
Lorenzo Bertani, Corrado Blandizzi, Maria Gloria Mumolo, Linda Ceccarelli, Eleonora Albano, Gherardo Tapete, Giovanni Baiano Svizzero, Federico Zanzi, Francesca Coppini, Nicola de Bortoli, Massimo Bellini, Riccardo Morganti, Santino Marchi, Francesco Costa. Fecal Calprotectin Predicts Mucosal Healing in Patients With Ulcerative Colitis Treated With Biological Therapies: A Prospective Study. Clinical and Translational Gastroenterology 2020; 11(5): e00174 doi: 10.14309/ctg.0000000000000174
|
| 90 |
Julian Häger, Holger Bang, Melanie Hagen, Michael Frech, Pascal Träger, Maria V. Sokolova, Ulrike Steffen, Koray Tascilar, Kerstin Sarter, Georg Schett, Jürgen Rech, Mario M. Zaiss. The Role of Dietary Fiber in Rheumatoid Arthritis Patients: A Feasibility Study. Nutrients 2019; 11(10): 2392 doi: 10.3390/nu11102392
|
| 91 |
Sarvesh Agarwal, Vijay Pratap Singh, Paulamy Ganguly, Pujita Munnangi, Claire Collins, Sadmaan Sarker, Jason Shenoi, Scott Heston, Shruti Pandita, Tej K. Pandita, Michael Moreno, Douglas A. Baxter, Roderick I. Pettigrew, Shameer Khader, Kamlesh K. Yadav. Comprehensive Precision Medicine. 2024; : 625 doi: 10.1016/B978-0-12-824010-6.00051-4
|
| 92 |
Amihai Rottenstreich, Tali Mishael, Sorina Grisaru Granovsky, Benjamin Koslowsky, Hagai Schweistein, Guila Abitbol, Eran Goldin, Ariella Bar-Gil Shitrit. Clinical utility of fecal calprotectin in monitoring disease activity and predicting relapse in pregnant patients with inflammatory bowel diseases. European Journal of Internal Medicine 2020; 77: 105 doi: 10.1016/j.ejim.2020.03.015
|
| 93 |
Olga Maria Nardone, Uday Nagesh Shivaji, Vittoria Ferruzza, Subrata Ghosh, Marietta Iacucci. Soluble Blood Markers of Mucosal Healing in Inflammatory Bowel Disease: The Future of Noninvasive Monitoring. Inflammatory Bowel Diseases 2020; 26(6): 961 doi: 10.1093/ibd/izz226
|
| 94 |
Brandon J. Harder, Annemarie N. Lekkerkerker, Ellen P. Casavant, Jason A. Hackney, Allen Nguyen, Jacqueline M. McBride, William Rodney Mathews, Veronica G. Anania. Comprehensive profiling of the human fecal proteome from IBD patients with DIA‐MS enables evaluation of disease‐relevant proteins. PROTEOMICS – Clinical Applications 2024; doi: 10.1002/prca.202300075
|
| 95 |
Lorenzo Bertani, Claudia D’Alessandro, Marco Fornili, Francesca Coppini, Federico Zanzi, Luca Carmisciano, Francesca Geri, Giovanni Baiano Svizzero, Emma Maria Rosi, Alice De Bernardi, Linda Ceccarelli, Maria Gloria Mumolo, Laura Baglietto, Massimo Bellini, Nicola De Bortoli, Francesco Costa. Response to Ustekinumab Therapy Is Associated with an Improvement of Nutritional Status in Patients with Crohn’s Disease. Journal of Clinical Medicine 2023; 12(19): 6118 doi: 10.3390/jcm12196118
|
| 96 |
Kathrin Bausch, Elisa Roth, Stefan Heinz, David Horst, Susanne Mathia, Tatjana Vlajnic, Lukas Bubendorf, Timm Westhoff, Christian Wetterauer, Hans Helge Seifert, Jan Ebbing, Sarah P. Psutka. Urinary Calprotectin loses specificity as tumour marker due to sterile leukocyturia associated with bladder cancer. PLOS ONE 2019; 14(3): e0213549 doi: 10.1371/journal.pone.0213549
|
| 97 |
Gabriele Dragoni, Tommaso Innocenti, Andrea Galli. Biomarkers of Inflammation in Inflammatory Bowel Disease: How Long before Abandoning Single-Marker Approaches?. Digestive Diseases 2021; 39(3): 190 doi: 10.1159/000511641
|
| 98 |
Giuseppe Acri, Valentina Venuti, Stefano Costa, Barbara Testagrossa, Salvatore Pellegrino, Vincenza Crupi, Domenico Majolino. Raman Spectroscopy as Noninvasive Method of Diagnosis of Pediatric Onset Inflammatory Bowel Disease. Applied Sciences 2020; 10(19): 6974 doi: 10.3390/app10196974
|
| 99 |
Mario García-Alanis, Liz Toapanta-Yanchapaxi, Arturo Reyes-Velásquez, Fernando Mancilla, Isela Pérez-Mayo, Jesús K. Yamamoto-Furusho. The interrelation between anxiety and quality of life among patients with ulcerative colitis in remission. Gastroenterología y Hepatología 2023; 46(10): 747 doi: 10.1016/j.gastrohep.2023.01.003
|
| 100 |
Mariangela Manfredi, Lieve Van Hoovels, Maurizio Benucci, Riccardo De Luca, Carmela Coccia, Pamela Bernardini, Edda Russo, Amedeo Amedei, Serena Guiducci, Valentina Grossi, Xavier Bossuyt, Carlo Perricone, Maria Infantino. Circulating Calprotectin (cCLP) in autoimmune diseases. Autoimmunity Reviews 2023; 22(5): 103295 doi: 10.1016/j.autrev.2023.103295
|
| 101 |
Alessandro Armuzzi, Yoram Bouhnik, Fraser Cummings, Marion Bettey, Burkhard Pieper, Taegyun Kang. Enhancing treatment success in inflammatory bowel disease: Optimising the use of anti-TNF agents and utilising their biosimilars in clinical practice. Digestive and Liver Disease 2020; 52(11): 1259 doi: 10.1016/j.dld.2020.06.008
|
| 102 |
Kohei Wagatsuma, Yoshihiro Yokoyama, Hiroshi Nakase. Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease. Life 2021; 11(12): 1375 doi: 10.3390/life11121375
|
| 103 |
Antonio Facciorusso, Daryl Ramai, Cristina Ricciardelli, Rosa Paolillo, Marcello Maida, Saurabh Chandan, Babu P. Mohan, Viktor Domislovic, Rodolfo Sacco. Prognostic Role of Post-Induction Fecal Calprotectin Levels in Patients with Inflammatory Bowel Disease Treated with Biological Therapies. Biomedicines 2022; 10(9): 2305 doi: 10.3390/biomedicines10092305
|
| 104 |
Valérie Sinniger, Sonia Pellissier, Florence Fauvelle, Candice Trocmé, Dominique Hoffmann, Laurent Vercueil, Jean‐Luc Cracowski, Olivier David, Bruno Bonaz. A 12‐month pilot study outcomes of vagus nerve stimulation in Crohn's disease. Neurogastroenterology & Motility 2020; 32(10) doi: 10.1111/nmo.13911
|
| 105 |
Mohammad Aadil Bhat, Iqra Usman, Suneela Dhaneshwar. Application of Drug Repurposing Approach for Therapeutic Intervention
of Inflammatory Bowel Disease. Current Reviews in Clinical and Experimental Pharmacology 2024; 19(3): 234 doi: 10.2174/0127724328245156231008154045
|
| 106 |
Loredana Goran, Monica State, Ana Maria Negreanu, Lucian Negreanu. Pursuing therapeutic success in Crohn’s disease: A matter of definition, tools and longterm outcomes. European Journal of Inflammation 2020; 18: 205873922096289 doi: 10.1177/2058739220962896
|
| 107 |
Anne Marita Milde, Anne Marie Kinn Rød, Silvia Brekke, Hedda Gjøen, Ghenet Mesfin, Robert Murison, Alexandra Kavushansky. Does a single exposure to social defeat render rats more vulnerable to chemically induced colitis than brief inescapable foot-shocks?. PLOS ONE 2022; 17(8): e0263802 doi: 10.1371/journal.pone.0263802
|
| 108 |
Mario García-Alanis, Liz Toapanta-Yanchapaxi, Arturo Reyes-Velásquez, Fernando Mancilla, Isela Pérez-Mayo, Jesús K. Yamamoto-Furusho. The interrelation between anxiety and quality of life among patients with ulcerative colitis in remission. Gastroenterología y Hepatología (English Edition) 2023; 46(10): 747 doi: 10.1016/j.gastre.2023.11.001
|
| 109 |
S. Ali Naqvi, Lorian M. Taylor, Remo Panaccione, Subrata Ghosh, Herman W. Barkema, Naomi Hotte, Nusrat Shommu, Sandeep Kaur, Raylene A. Reimer, Karen L. Madsen, Maitreyi Raman. Dietary patterns, food groups and nutrients in Crohn’s disease: associations with gut and systemic inflammation. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-020-80924-8
|
| 110 |
Benoît Thomas P Gilbert, Raul Yhossef Tito Tadeo, Celine Lamacchia, Olivia Studer, Delphine Courvoisier, Jeroen Raes, Axel Finckh. Gut microbiome and intestinal inflammation in preclinical stages of rheumatoid arthritis. RMD Open 2024; 10(1): e003589 doi: 10.1136/rmdopen-2023-003589
|
| 111 |
Viktor Domislovic, Joachim Høg Mortensen, Majken Lindholm, Morten Asser Kaarsdal, Marko Brinar, Ana Barisic, Tina Manon-Jensen, Zeljko Krznaric. Inflammatory Biomarkers of Extracellular Matrix Remodeling and Disease Activity in Crohn’s Disease and Ulcerative Colitis. Journal of Clinical Medicine 2022; 11(19): 5907 doi: 10.3390/jcm11195907
|
| 112 |
Lorenzo Bertani, Giorgia Bodini, Maria Gloria Mumolo, Nicola de Bortoli, Linda Ceccarelli, Leonardo Frazzoni, Gherardo Tapete, Eleonora Albano, Maria Corina Plaz Torres, Massimo Bellini, Edoardo Savarino, Vincenzo Savarino, Santino Marchi, Francesco Costa. Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative Colitis. Digestive Diseases and Sciences 2020; 65(8): 2397 doi: 10.1007/s10620-019-05959-y
|
| 113 |
Lorenzo Bertani, Luca Antonioli, Matteo Fornai, Gherardo Tapete, Giovanni Baiano Svizzero, Santino Marchi, Corrado Blandizzi, Francesco Costa. Evaluation of cytokine levels as putative biomarkers to predict the pharmacological response to biologic therapy in inflammatory bowel diseases. Minerva Gastroenterologica e Dietologica 2020; 65(4) doi: 10.23736/S1121-421X.19.02621-7
|
| 114 |
V. M. Makhov, L. V. Romasenko, A. S. Panferov, Yu. A. Doroninа, M. A. Isaykina, M. V. Yurazh. Clinical and psychiatric comparison of diverticular disease of the colon and irritable bowel syndrome. Experimental and Clinical Gastroenterology 2020; (10): 71 doi: 10.31146/1682-8658-ecg-182-10-71-77
|
| 115 |
G. Sarrabayrouse, A. Elias, F. Yáñez, L. Mayorga, E. Varela, C. Bartoli, F. Casellas, N. Borruel, C. Herrera de Guise, K. Machiels, S. Vermeire, C. Manichanh, Mariana X. Byndloss. Fungal and Bacterial Loads: Noninvasive Inflammatory Bowel Disease Biomarkers for the Clinical Setting. mSystems 2021; 6(2) doi: 10.1128/mSystems.01277-20
|
| 116 |
Lorenzo Bertani, Brigida Barberio, Marco Fornili, Luca Antonioli, Federico Zanzi, Cesare Casadei, Laura Benvenuti, Sonia Facchin, Vanessa D'Antongiovanni, Greta Lorenzon, Linda Ceccarelli, Laura Baglietto, Nicola de Bortoli, Massimo Bellini, Francesco Costa, Edoardo Vincenzo Savarino, Matteo Fornai. Serum oncostatin M predicts mucosal healing in patients with inflammatory bowel diseases treated with anti-TNF, but not vedolizumab. Digestive and Liver Disease 2022; 54(10): 1367 doi: 10.1016/j.dld.2022.03.008
|
| 117 |
Giorgio Guglielmi, Stefania Crucitta, Lorenzo Bertani, Martina Ruglioni, Giovanni Baiano Svizzero, Linda Ceccarelli, Marzia Del Re, Romano Danesi, Francesco Costa, Stefano Fogli. Expression of Circulating let-7e and miR-126 May Predict Clinical Remission in Patients With Crohn’s Disease Treated With Anti-TNF-α Biologics. Inflammatory Bowel Diseases 2024; 30(3): 441 doi: 10.1093/ibd/izad181
|
| 118 |
Nader D Daoud, Jana G Hashash, Michael F Picco, Francis A Farraye. Faecal Calprotectin from Ileostomy Output Is Sensitive and Specific for the Prediction of Small Bowel Inflammation in Patients with Crohn’s Disease. Journal of Crohn's and Colitis 2022; 16(4): 601 doi: 10.1093/ecco-jcc/jjab182
|
| 119 |
Ronaldo Teixeira da Silva Júnior, Jonathan Santos Apolonio, Jessica Oliveira de Souza Nascimento, Bruna Teixeira da Costa, Luciano Hasimoto Malheiro, Marcel Silva Luz, Lorena Sousa de Carvalho, Cleiton da Silva Santos, Fabrício Freire de Melo. Crohn's disease and clinical management today: How it does?. World Journal of Methodology 2023; 13(5): 399-413 doi: 10.5662/wjm.v13.i5.399
Abstract(165) |
Core Tip(148) |
Full Article(HTML)(1377)
|
Full Article with Cover (PDF)-3053K(23)
|
Full Article (Word)-2230K(15)
|
Audio-289K(3)
|
Peer-Review Report-182K(15)
|
Answering Reviewers-53K(24)
|
Full Article (PDF)-2799K(68)
|
Full Article (XML)-263K(21)
|
Times Cited (0)
|
Total Visits (2166)
|
Open
|
| 120 |
Lluís Puig. The safety of ixekizumab in psoriasis drug therapy. Expert Opinion on Drug Safety 2020; 19(2): 117 doi: 10.1080/14740338.2020.1709440
|